The Week in Review: December 1 – December 8, 2017

Friday, December 8, 2017 News Recap: URGENT BC Patient and Caregiver Input Request: Vosevi. We need to hear your voice! Patient and Caregiver input is requested by BC PharmaCare on Gilead’s combo of sofosbuvir, velpatasvir, and voxilaprevir (SOF-VEL-VOX or Vosevi™) for Genotypes 1-6. Personal Stories This week we have two great stories of triumphing over HepC: Aidain’s ‘I will never forget the day I found out I had hepatitis c’, and Patric...

Hep C and me: ‘I was nauseous all the time. I couldn’t gain weight. My skin was itchy and raw’

WHEN I WAS diagnosed with Hepatitis C in the 1990s I was told I’d loads of more serious problems I had to deal with first. I remember getting the result and the doctor turning to me and saying, Patrick, it’ll kill you in 30 years so don’t worry about it. I was using drugs. I’d washed up to an addiction service, exhausted from the drugs, exhausted from the chaos of it all. I was tested. I was given advice that at the time that somehow made sense. Thirty

No valid evidence $40,000 miracle drug cures hepatitis C – study

Note from CD:  Woke up to this new report this morning and almost got hysterical.  Whatever the financial/political motivation behind this report, I know I speak for many others in the HCV community (patients and physicians) who KNOW that this is NOT TRUE. While, unfortunately, some with late-stage disease although they have cleared the virus have not improved (because they were treated too late and too much damage was done), we know that the DAAs work, re

Antiviral Drug Prevents Recurrence of Hepatitis C in Liver Transplant Patients

Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine phase II clinical trial. The finding suggests that the therapy might be an effective approach to preventing reinfection in such patients. Josh Levitsky, MD, MS, professor of Medicine in the Division of Gastroenterology and Hepatology, was the co...

“Miraculous,” new treatment for Hep C

Less than one percent of Albertans suffer from Hepatitis C, but despite that seemingly low number Dr. Mark Swain with the University of Calgary calls the infection, “prevalent.” That measurement comes in at some 40,000 people. Well, as Dr. Swain tells the Alberta Morning News, a new drug that’s just been approved seeks to help end Hep C. Epclusa is a combination of 2 drugs in one pill, with an enviable success rate. Read more...http://www.630ched.co

First Canadian Study Demonstrates Potential to Remove Patients from Active Liver Transplant List After Curing Hepatitis C

- "The Days of Hepatitis C Dominating Liver Transplantation Are Numbered" - LONDON, ON, May 3, 2016 /CNW/ - Researchers with the Multi-Organ Transplant Program at London Health Sciences Centre and the Lawson Health Research Institute have been able to remove one-third (33 per cent) of patients from the active liver transplant waiting list by "curing" them of their Hepatitis C disease.  This is the first Canadian data that demonstrates the benefit of treat...

Pamela Anderson Cured of Hepatitis C But Others Wait for Miracle Drug

Anderson said the treatment cost around $100,000 and was covered by her health insurance. Healthy once more, Anderson is back focusing on projects like her cooking show and vegan shoe line.But not everyone is so lucky.Shima Andre, a 42-year-old Hepatitis C sufferer living in California, has health insurance and was prescribed an alternate version of the drug called Harvoni, but she was originally denied coverage after her disease was not deemed advanced en

Sex, drugs, rock ’n’ roll – then hepatitis C treatment

In his youth, Andrew Loog Oldham epitomized the Swinging Sixties. The idiosyncratic manager discovered the Rolling Stones and produced some of their classic songs, including 19th Nervous Breakdown, Mother’s Little Helper, Lady Jane, Ruby Tuesday and Paint It Black. He formed Britain’s first independent record label, which recorded Rod Stewart, Eric Clapton and Fleetwood Mac, and for a time he worked with the Beatles.Oldham also had a 30-year history with d